US Stock MarketDetailed Quotes
BJDX Bluejay Diagnostics
- 0.5510
- +0.0011+0.20%
Close Apr 25 16:00 ET
- 0.6192
- +0.0682+12.38%
Post 18:14 ET
1.48MMarket Cap-60P/E (TTM)
0.6399High0.5120Low19.12KVolume0.5120Open0.5499Pre Close10.70KTurnover1.01%Turnover RatioLossP/E (Static)2.69MShares13.979952wk High0.51P/B1.04MFloat Cap0.470352wk Low--Dividend TTM1.90MShs Float125.0000Historical High--Div YieldTTM23.26%Amplitude0.4703Historical Low0.5590Avg Price1Lot Size
About Bluejay Diagnostics Company
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
Company Profile
SymbolBJDX
Company NameBluejay Diagnostics
Listing DateNov 10, 2021
Issue Price10.00
Founded2015
CEOMr. Neil Dey
MarketNASDAQ
Employees10
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address360 Massachusetts Avenue,Suite 203
CityActon
ProvinceMassachusetts
CountryUnited States of America
Zip Code01720
Phone1-978-631-4884
Websitehttp://www.bluejaydx.com
Company Executives
- Name
- Position
- Salary
- Neil Dey
- Principal Financial and Accounting Officer, President, Chief Executive Officer and Director
- 292.15K
- Dr. Jason Cook
- Chief Technology Officer
- 240.29K
- Douglas C. Wurth
- Chairman of the Board
- 109.60K
- Svetlana Dey
- Director
- 62.10K
- Gary Gemignani
- Independent Director
- 89.60K
- Fred S. Zeidman
- Independent Director
- 82.10K
- Donald R. Chase
- Independent Director
- 97.10K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg